| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
HOOKIPA Pharma Inc (NASDAQ: HOOK)
HOOK Technical Analysis
5
| As on 9th Jun 2023 HOOK STOCK Price closed @ 1.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.62 & Strong Sell for SHORT-TERM with Stoploss of 1.92 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HOOKSTOCK Price
| Open | 1.08 | Change | Price | % |
| High | 1.10 | 1 Day | -0.09 | -8.18 |
| Low | 1.00 | 1 Week | -0.30 | -22.90 |
| Close | 1.01 | 1 Month | 0.00 | 0.00 |
| Volume | 1392700 | 1 Year | -1.47 | -59.27 |
| 52 Week High 2.52 | 52 Week Low 0.71 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| HOOK Daily Charts |
HOOK Intraday Charts |
Whats New @ Bazaartrend |
HOOK Free Analysis |
|
|
HOOK Important Levels Intraday
| RESISTANCE | 1.20 |
| RESISTANCE | 1.14 |
| RESISTANCE | 1.10 |
| RESISTANCE | 1.06 |
| SUPPORT | 0.96 |
| SUPPORT | 0.92 |
| SUPPORT | 0.88 |
| SUPPORT | 0.82 |
HOOK Forecast April 2024
| 4th UP Forecast | 3.19 |
| 3rd UP Forecast | 2.49 |
| 2nd UP Forecast | 2.06 |
| 1st UP Forecast | 1.63 |
| 1st DOWN Forecast | 0.39 |
| 2nd DOWN Forecast | -0.04 |
| 3rd DOWN Forecast | -0.47 |
| 4th DOWN Forecast | -1.17 |
HOOK Weekly Forecast
| 4th UP Forecast | 1.67 |
| 3rd UP Forecast | 1.46 |
| 2nd UP Forecast | 1.33 |
| 1st UP Forecast | 1.20 |
| 1st DOWN Forecast | 0.82 |
| 2nd DOWN Forecast | 0.69 |
| 3rd DOWN Forecast | 0.56 |
| 4th DOWN Forecast | 0.35 |
HOOK Forecast2024
| 4th UP Forecast | 5.58 |
| 3rd UP Forecast | 4.11 |
| 2nd UP Forecast | 3.21 |
| 1st UP Forecast | 2.3 |
| 1st DOWN Forecast | -0.28 |
| 2nd DOWN Forecast | -1.19 |
| 3rd DOWN Forecast | -2.09 |
| 4th DOWN Forecast | -3.56 |
HOOKIPA Pharma Inc ( NASDAQ USA Symbol : HOOK )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HOOK Business Profile
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York. Address: 350 Fifth Avenue, New York, NY, United States, 10118
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service